Ethocle Reports has published its latest Market Research Report on Ragweed Pollen Allergy – Pipeline Review, H1 2017. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Browse market data tables and figures.
Published On: 15-Mar-2017 | Pages: 26
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy – Pipeline Review, H1 2017, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape.
Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid.
Pharmaceutical and Healthcare latest pipeline guide Ragweed Pollen Allergy – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Ragweed Pollen Allergy (Immunology).
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ragweed Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ragweed Pollen Allergy (Immunology).
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Global Markets Direct Report Coverage
Ragweed Pollen Allergy – Overview
ASIT Biotech SA
Astellas Pharma Inc
Ragweed Pollen Allergy – Drug Profiles